Patents
Patents for C07C 239 - Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof (5,130)
03/2009
03/18/2009CN101389619A Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
02/2009
02/17/2009US7491846 reacting sulfate, hydrochloride, nitrate or phosphate salts of hydroxylamine with a bases, while keeping the reaction solution at a pH of 7 or more, then purifying the hydroxylamine by ion exchange and concentrating by distillation
02/17/2009US7491817 Silica base, an acyl or aroyl substituent, and an acid labile dimethoxytrityl group; "universal" solid support
02/04/2009CN101357895A Method for synthesizing methoxamine hydrochloride
02/04/2009CN101357894A Method for selectively reducing preparation of arylhydroxylamine from aromatic nitro compound
01/2009
01/28/2009CN101353320A Matrix metalloprotease inhibitors, medicinal composition containing the same, preparation and use thereof
01/22/2009US20090023812 N,n-dihalogenated amino acids and derivatives
01/20/2009CA2502856C Intermediates for retroviral protease inhibiting compounds
01/13/2009CA2301035C Electrosynthesis of hydroxylammonium salts and hydroxylamine using a mediator, a catalytic film, methods of making the catalytic film, and electrosynthesis of compounds using the catalytic film
12/2008
12/30/2008US7470817 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried
12/24/2008WO2007115185A3 Preparation of chiral amides and amines
12/24/2008DE102007028198A1 New alkyl-ketone compounds are histone deacetylase inhibitors, useful to treat e.g. cancer, hematologic or solid tumors, non-Hodgkins tumors, T-cell lymphoma, type I diabetes or Hashimoto's thyroiditis, and to modulate e.g. cell cycle
12/16/2008CA2302937C Method for producing (hetero)aromatic hydroxylamines
12/09/2008US7462361 N,N-dihalogenated amino acids and derivatives
11/2008
11/18/2008US7452999 Chemical process for the preparation of intermediates to obtain N-formyl hydroxy-lamine compounds
11/13/2008WO2008135041A1 Adamantyloxyamine derivatives and related compounds for use as nmda and/or dpp-4 modulators for the therapy of cns diseases and diabetes
11/13/2008DE102007022007A1 Neuartike Pharmazeutika, Verfahren zu ihrer Herstellung und ihre Verwendung in der Prophylaxe und Therapie von ZNS-Erkrankungen und Diabetes Neuartike pharmaceuticals, to processes for their preparation and their use in the prophylaxis and treatment of CNS disorders and diabetes
11/06/2008WO2008030883A3 Treatment of cancer
10/2008
10/30/2008US20080269221 Antibacterial agents
10/30/2008US20080268537 Free of nitrone; for reducing oxidative damage or delaying senescence
10/28/2008US7442830 Proteasome inhibitors
10/14/2008US7435850 2-Fluoro-N-[3-hydroxy-2-(7-methoxy-1-naphthyl)propyl]acetamide, its enantiomers, and addition salts; melatoninergic disorders, circadian rhythm disorders, antidepressants, seasonal affective disorders, sleep disorders, jetlag
10/09/2008US20080245233 Method for Inhibiting Fouling in Basic Washing Systems
10/07/2008US7432396 Process for producing (Z)-1-phenyl-1-diethylaminocarbonyl-2-hydroxymethylcyclopropane
10/07/2008US7432389 Inhibiting beta-secretase enzyme activity and A beta peptide production, to reduce amyloid beta deposits or plaques
10/02/2008WO2008117844A1 Method for producing arylhydroxylamine
09/2008
09/23/2008CA2378382C Carboxylic acid amides, pharmaceutical compositions containing these compounds, the use and preparation thereof
09/16/2008US7425652 Preparation of alkanolamines
09/16/2008US7425247 by simultaneous countercurrent treatment of hydroxyl ammonium sulfate with ammonia or ammonia water, then separation by distillation and concentration of the solution in a countercurrent flow with a stripping medium comprising a mixture of steam and a noncondensable inert gas
09/09/2008US7423154 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates
09/02/2008US7420089 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
09/02/2008US7420087 Method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof
08/2008
08/28/2008WO2008102348A1 Alpha-halo- and alpha-alkyl-cyclopropylcarboxy compounds and uses thereof
08/26/2008US7417168 Method for preparing hydroxylamine
08/20/2008EP1525161B1 Method for producing a solid containing zeolites
08/20/2008CN101247799A Inhibitors of fibroblast activation protein alpha
08/13/2008CN101243043A Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field
08/13/2008CN101239929A Trichostatin A derivatives, preparation method and use thereof
08/12/2008US7411001 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
07/2008
07/29/2008CA2214323C Compounds and compositions for delivering active agents
07/15/2008US7399885 Method for preparing hydroxylamine
07/09/2008CN101218171A Hydroxylammonium continuous production process
07/08/2008US7396959 Process for preparing symmetrical and unsymmetrical N,N-dihydrocarbylhydroxylamines
07/08/2008US7396519 Hydroxylammonium sulfate, sodium hydroxide, ammonia; hydroxyanthraquinone stabilizer feed to reactor at a low temperature; fluidized bed ion exchange resin; reduced risks of explosion
06/2008
06/26/2008WO2008074227A1 Synthetic ion channels
06/24/2008US7390924 Terphenyl derivatives, preparation thereof, compositions containing same
06/19/2008US20080146740 Process for the controlled increase in the molecular weight of polyethylenes
06/03/2008US7381843 Method for preparing hydroxylamine
06/03/2008US7381827 Processes and intermediates
05/2008
05/29/2008WO2008061616A1 Process for preparing 2-aminooxyethanol
05/28/2008EP1925610A1 Production process of 2-aminooxyethanol
05/15/2008WO2008056768A1 Metal catalyst carrying carbon/ethylenediamine composites and process for production thereof
05/14/2008CN101180266A Alpha ketoamide compounds as cysteine protease inhibitors
05/07/2008CN201056549Y Safety device of rectifying tower for atmospheric intermittent separation of N, O-dimethyl group hydroxylamine
04/2008
04/29/2008US7365085 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption
04/29/2008CA2259203C Method for the synthesis of amines and amino acids with organoboron derivatives
04/29/2008CA2254833C Pharmaceutical for treatment of neurological and neuropsychiatric disorders
04/23/2008CN101166712A Hydroxamic acid derivatives and the preparation method thereof
04/22/2008US7361755 Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines
04/16/2008EP1909783A2 Illudin analogs useful as anticancer agents
04/15/2008US7358365 Process for the controlled increase in the molecular weight of polyethylenes
04/15/2008US7358359 Antibacterial agents
03/2008
03/26/2008EP1901994A1 Process for the continuous production of hydroxylammonium
03/19/2008EP1898899A1 Inhibitors of fibroblast activation protein alpha
03/19/2008EP1283711B1 Peptide deformylase inhibitors
03/13/2008WO2008029090A1 Chemical process
02/2008
02/20/2008EP1888510A2 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
02/06/2008CN100366605C Compounds to treat alzheimer's disease
01/2008
01/31/2008WO2008013334A1 Deformylase inhibitor, process for the preparation thereof, and composition comprising the same
01/30/2008CN100364963C Preparation of O-substituted hydroxylamines
01/29/2008US7323596 Antibacterial or antiprotozoal activity: formula (1) formula (2) wherein: Z represents a radical of formula N(OH)CH( .dbd. O) or of formula C( .dbd. O)NH(OH); R1 represents hydrogen, methyl or trifluoromethyl, or, except when Z is a radical of
01/29/2008US7323594 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried
01/17/2008US20080015388 Method for preparing hydroxylamine
01/16/2008CN101104594A Method of purifying/concentrating sugar chain with sugar chain-trapping molecule and method of analyzing sugar chain structure
01/09/2008CN100360580C Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and alpha, beta-unsaturated carboxylic acid and aldehyde compounds
12/2007
12/26/2007CN101092342A Chemical process for the preparation of intermediates to obtain n-formyl hydroxy-lamine compounds
12/20/2007US20070293547 Compounds and Compositions as Lxr Modulators
12/19/2007EP1866279A2 Alkylated and polymeric macromolecular antioxidants and methods of making and using the same
12/19/2007EP1866276A1 Alpha ketoamide compounds as cysteine protease inhibitors
12/19/2007EP1115693B9 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
12/18/2007US7309802 Preparation of isoxazolin-3-ylacylbenzene
12/06/2007DE102006026329A1 Verfahren zur Herstellung von enantiomerenangereicherten Hydroxylaminderivaten A process for the preparation of enantiomerically enriched hydroxylamine
12/05/2007EP1862446A2 Method for manufacturing enantiomer-enriched hydroxylamine derivatives
11/2007
11/29/2007US20070276138 Modulators of peroxisome proliferator activated receptors
11/28/2007CN100351228C Hydroxamic acid derivatives and the method for preparing thereof
11/20/2007US7297819 Open-chain alkoxyamines and their corresponding nitroxides for controlled low temperature radical polymerization
11/15/2007US20070265471 Pretreating the acidic buffer solution with tertiary amine compounds thereby removing metal impurities from the acidic buffer solution; reducing nitrate in the acidic buffer solution with hydrogen to give hydroxylamine in the presence of catalysts
11/14/2007CN101070291A N-OR amides compound, its preparing method and use
11/14/2007CN100348485C Production of a zeolite-containing solid
11/14/2007CN100348476C Preparation of a high purity and high concentration hydroxylamine free base
11/06/2007US7291728 Spirolactams and their synthesis
11/06/2007CA2223112C 1,2-bis-adducts of stable nitroxides with substituted ethylenes and stabilized compositions
10/2007
10/31/2007EP0910564B1 D-amino acid derived inhibitors of cysteine and serine proteases
10/18/2007US20070244197 Bactericide against gramnegative bacteria; respiratory system disorders
10/17/2007CN101056893A N-substituted imides as polymerization initiators
10/11/2007US20070238781 Compounds for the modulation of the glykolysis-enzyme-and/or of the transaminase-complex
10/11/2007CA2648121A1 Preparation of chiral amides and amines
10/09/2007US7279601 Optically active α-aminooxyketone derivatives and process for production thereof
09/2007
09/26/2007EP0844993B1 Pesticidal indazole derivatives
09/20/2007US20070219274 (R)-Chiral Halogenated Substituted Fused Heterocyclic Amino Compounds Useful for Inhibiting Cholesterol Ester Transfer Protein Activity
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 52